Adherence to secondary prevention measures after acute coronary syndrome in patients associated exclusively with the public and private healthcare systems in Brazil.
Cardiovascular
Exercise
Global health
Healthcare quality
Recurrence
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
22
04
2022
revised:
28
07
2022
accepted:
27
08
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
epublish
Résumé
Adherence to secondary prevention measures after acute coronary syndrome (ACS) is essential to prevent disease recurrence. In Brazil, the Brazilian Unified Health System (SUS, in Portuguese), and the private healthcare system (PHCS) coexist. We aimed to evaluate the adherence to secondary prevention in patients with ACS who were assisted by either SUS or PHCS. In this longitudinal prospective study, patients with ACS were admitted to the four cardiological reference hospitals of Sergipe, three of which assisted PHCS users, and one, SUS users. We analyzed the two patient care models with multiple logistic regression models for adherence to physical activity, pharmacotherapy, and smoking cessation. We enrolled 581 volunteers in this study: 44.1 % from SUS and 55.9 % from PHCS. PHCS users showed greater adherence to pharmacotherapy at both 30 and 180 (p = 0.001) days after ACS with better results in all classes of medications (p < 0.05) than SUS users did. They also showed better adherence to physical activity (p = 0.047). There was no distinction between the groups regarding smoking cessation. The secondary prevention measures after ACS were more effective in PHCS users than in SUS users due to better adherence, especially to pharmacotherapy and regular physical activity.
Identifiants
pubmed: 36161134
doi: 10.1016/j.pmedr.2022.101973
pii: S2211-3355(22)00280-7
pmc: PMC9502285
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101973Informations de copyright
© 2022 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Int J Cardiol. 2020 Jun 15;309:1-7
pubmed: 32220487
BMC Cardiovasc Disord. 2019 Nov 6;19(1):243
pubmed: 31694556
J Am Coll Cardiol. 2013 Mar 12;61(10):1069-75
pubmed: 23375933
Am J Cardiol. 2020 Feb 1;125(3):370-375
pubmed: 31761149
Int J Cardiol. 2019 Jan 15;275:1-5
pubmed: 30391064
J Phys Act Health. 2020 Dec 04;18(1):76-85
pubmed: 33276323
Nutrition. 2019 Mar;59:131-137
pubmed: 30471525
Arq Bras Cardiol. 2019 May;112(5):564-570
pubmed: 30892386
Open Heart. 2015 Jan 24;2(1):e000166
pubmed: 25713726
Clin Pract. 2022 Jul 08;12(4):513-526
pubmed: 35892441
JAMA Intern Med. 2014 Feb 1;174(2):186-93
pubmed: 24247275
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Int J Cardiol. 2019 Dec 1;296:8-14
pubmed: 31256995
Cien Saude Colet. 2017 Jan;22(1):179-190
pubmed: 28076541
Arq Bras Cardiol. 2021 Mar;116(3):516-658
pubmed: 33909761
Arch Phys Med Rehabil. 2020 Apr;101(4):650-657
pubmed: 31904342
Eur Heart J. 2012 Oct;33(20):2569-619
pubmed: 22922416
PLoS One. 2017 Aug 29;12(8):e0183905
pubmed: 28850579
Arq Bras Cardiol. 2014 Aug;103(2 Suppl 1):1-31
pubmed: 25387466
JAMA Cardiol. 2016 Sep 1;1(6):718-30
pubmed: 27438381
Arq Bras Cardiol. 2021 Jul;117(1):181-264
pubmed: 34320090
Int J Cardiol. 2020 Jul 1;310:159-161
pubmed: 32276770
Heart Lung. 2017 Sep - Oct;46(5):357-362
pubmed: 28801110
Rev Saude Publica. 2010 Jun;44(3):559-65
pubmed: 20549022
Lancet. 2013 Nov 23;382(9906):1714-22
pubmed: 24004642
J Phys Act Health. 2020 Jun 12;17(7):744-755
pubmed: 32531762
Arq Bras Cardiol. 2019 Jun 27;113(1):42-49
pubmed: 31271598
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
pubmed: 24239923
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Am J Cardiol. 2019 Aug 15;124(4):491-498
pubmed: 31221462
J Am Coll Cardiol. 2015 Jan 6;65(1):43-51
pubmed: 25572509
Int J Cardiol. 2020 Feb 1;300:20-26
pubmed: 31371116
J Hypertens. 2015 Feb;33(2):266-74
pubmed: 25380147
JAMA. 2013 Apr 17;309(15):1613-21
pubmed: 23592106